Abeona Therapeutics Inc. (ABEO) vs BridgeBio Oncology Therapeutics Inc. (BBOT)
A side-by-side comparison of Abeona Therapeutics Inc. and BridgeBio Oncology Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.02HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
BBOT
BridgeBio Oncology Therapeutics Inc.
$3.54HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — ABEO vs BBOT
growth of $100 · dividends reinvested · last 3yABEO -3.2% (-1.1%/yr)BBOT -64.7% (-29.3%/yr)ABEO compounded faster over this window
ABEO BBOT
ABEO vs BBOT: by the numbers
- •ABEO is the larger company ($286M vs $283M market cap).
- •Both run net losses; BBOT's is the smaller (0.00% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | BBOT |
|---|---|---|
| P/S ratio | 11.20 | N/A |
| P/B ratio | 2.23 | 0.88 |
Profitability
| Metric | ABEO | BBOT |
|---|---|---|
| Gross margin | 73.68% | 0.00% |
| Operating margin | -1536.91% | 0.00% |
| Net margin | -246.42% | 0.00% |
| ROE | -49.11% | -56.36% |
| ROIC | -49.76% | -61.10% |
Growth (annualized)
| Metric | ABEO | BBOT |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| Total return CAGR (5Y) | -26.46% | N/A |
Go deeper
Dig into the metrics
Abeona Therapeutics ROEBridgeBio Oncology Therapeutics ROEAbeona Therapeutics operating marginBridgeBio Oncology Therapeutics operating marginAbeona Therapeutics revenue growthBridgeBio Oncology Therapeutics revenue growthAbeona Therapeutics free cash flowBridgeBio Oncology Therapeutics free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.